Cite
HARVARD Citation
Sica, M. et al. (2023). The long‐acting anti‐C5 ravulizumab results in C3 binding to PNH red cells similar to its parental molecule eculizumab. British journal of haematology. pp. e1-e4. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sica, M. et al. (2023). The long‐acting anti‐C5 ravulizumab results in C3 binding to PNH red cells similar to its parental molecule eculizumab. British journal of haematology. pp. e1-e4. [Online].